intellectual property
Invitae, OptraHealth Resolve Chatbot Patent Dispute
OptraHealth will license its automated genetic test result retrieval and return process to Invitae, while both companies continue to offer their own products.
Critics of the bill suggested that it would allow patents on pathogen genetic material, which could hamper the ability to test and treat in future pandemics.
European Patent Office Upholds ERS Genomics-Held CRISPR Patent
The CRISPR-Cas9-related patent, EPO Patent No. 3,401,400, had been opposed on grounds that it lacked novelty and inventiveness.
OptraHealth Sues Invitae for Infringement of AI-Based Chatbot Patent
OptraHealth claims that Invitae has violated its patent since the latter added results return capabilities to its Gia chatbot in February 2021.
Takara Bio USA Wins European Patent Challenge Filed by Jumpcode Genomics Over NGS Library Prep
The patent, granted in 2019, is part of Takara's portfolio covering methods used in RNA-sequencing library prep kits containing ZapR technology.